Extracorporeal membrane oxygenation in the newborn

K. P. Lally, R. Clark, C. Schwendeman, S. Harrell, B. Yoder, J. Carter, Donald Null

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) is used in the treatment of reversible pulmonary disease in the newborn. The ECMO program at Wilford Hall USAF Medical Center began in 1985 and to date, 57 patients have been placed on bypass for a mean of 125 hours. The indications for ECMO are severe, prolonged hypoxemia in patients with an estimated mortality of greater than 90% using conventional ventilator support. The major diagnoses in the patients placed on ECMO were meconium aspiration, congenital diaphragmatic hernia, and neonatal sepsis or pneumonia. Overall survival was 79%, or 45 out of 57. The most frequent complications were intracranial hemorrhage as well as hemorrhage from the surgical site. We have found ECMO to be an extremely valuable adjunct in the care of the critically ill newborn and believe it can significantly improve survival in infants with reversible pulmonary disease.

Original languageEnglish (US)
Pages (from-to)377-379
Number of pages3
JournalMilitary Medicine
Volume155
Issue number8
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Newborn Infant
Lung Diseases
Surgical Blood Loss
Meconium Aspiration Syndrome
Survival
Intracranial Hemorrhages
Mechanical Ventilators
Critical Illness
Pneumonia
Mortality

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Lally, K. P., Clark, R., Schwendeman, C., Harrell, S., Yoder, B., Carter, J., & Null, D. (1990). Extracorporeal membrane oxygenation in the newborn. Military Medicine, 155(8), 377-379.

Extracorporeal membrane oxygenation in the newborn. / Lally, K. P.; Clark, R.; Schwendeman, C.; Harrell, S.; Yoder, B.; Carter, J.; Null, Donald.

In: Military Medicine, Vol. 155, No. 8, 01.01.1990, p. 377-379.

Research output: Contribution to journalArticle

Lally, KP, Clark, R, Schwendeman, C, Harrell, S, Yoder, B, Carter, J & Null, D 1990, 'Extracorporeal membrane oxygenation in the newborn', Military Medicine, vol. 155, no. 8, pp. 377-379.
Lally KP, Clark R, Schwendeman C, Harrell S, Yoder B, Carter J et al. Extracorporeal membrane oxygenation in the newborn. Military Medicine. 1990 Jan 1;155(8):377-379.
Lally, K. P. ; Clark, R. ; Schwendeman, C. ; Harrell, S. ; Yoder, B. ; Carter, J. ; Null, Donald. / Extracorporeal membrane oxygenation in the newborn. In: Military Medicine. 1990 ; Vol. 155, No. 8. pp. 377-379.
@article{05d1e371de8a4367922c7243ed1de92b,
title = "Extracorporeal membrane oxygenation in the newborn",
abstract = "Extracorporeal membrane oxygenation (ECMO) is used in the treatment of reversible pulmonary disease in the newborn. The ECMO program at Wilford Hall USAF Medical Center began in 1985 and to date, 57 patients have been placed on bypass for a mean of 125 hours. The indications for ECMO are severe, prolonged hypoxemia in patients with an estimated mortality of greater than 90{\%} using conventional ventilator support. The major diagnoses in the patients placed on ECMO were meconium aspiration, congenital diaphragmatic hernia, and neonatal sepsis or pneumonia. Overall survival was 79{\%}, or 45 out of 57. The most frequent complications were intracranial hemorrhage as well as hemorrhage from the surgical site. We have found ECMO to be an extremely valuable adjunct in the care of the critically ill newborn and believe it can significantly improve survival in infants with reversible pulmonary disease.",
author = "Lally, {K. P.} and R. Clark and C. Schwendeman and S. Harrell and B. Yoder and J. Carter and Donald Null",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "155",
pages = "377--379",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "8",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation in the newborn

AU - Lally, K. P.

AU - Clark, R.

AU - Schwendeman, C.

AU - Harrell, S.

AU - Yoder, B.

AU - Carter, J.

AU - Null, Donald

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Extracorporeal membrane oxygenation (ECMO) is used in the treatment of reversible pulmonary disease in the newborn. The ECMO program at Wilford Hall USAF Medical Center began in 1985 and to date, 57 patients have been placed on bypass for a mean of 125 hours. The indications for ECMO are severe, prolonged hypoxemia in patients with an estimated mortality of greater than 90% using conventional ventilator support. The major diagnoses in the patients placed on ECMO were meconium aspiration, congenital diaphragmatic hernia, and neonatal sepsis or pneumonia. Overall survival was 79%, or 45 out of 57. The most frequent complications were intracranial hemorrhage as well as hemorrhage from the surgical site. We have found ECMO to be an extremely valuable adjunct in the care of the critically ill newborn and believe it can significantly improve survival in infants with reversible pulmonary disease.

AB - Extracorporeal membrane oxygenation (ECMO) is used in the treatment of reversible pulmonary disease in the newborn. The ECMO program at Wilford Hall USAF Medical Center began in 1985 and to date, 57 patients have been placed on bypass for a mean of 125 hours. The indications for ECMO are severe, prolonged hypoxemia in patients with an estimated mortality of greater than 90% using conventional ventilator support. The major diagnoses in the patients placed on ECMO were meconium aspiration, congenital diaphragmatic hernia, and neonatal sepsis or pneumonia. Overall survival was 79%, or 45 out of 57. The most frequent complications were intracranial hemorrhage as well as hemorrhage from the surgical site. We have found ECMO to be an extremely valuable adjunct in the care of the critically ill newborn and believe it can significantly improve survival in infants with reversible pulmonary disease.

UR - http://www.scopus.com/inward/record.url?scp=0024997771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024997771&partnerID=8YFLogxK

M3 - Article

VL - 155

SP - 377

EP - 379

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 8

ER -